✦ LIBER ✦

PCN118 Impact of Bone Metastases on Quality of Life in Patients With Castration-Resistant Prostate Cancer (CRPC) at High Risk for Developing Bone Metastases

✍ Scribed by G. Hechmati; J. Arellano; I. Haynes; O. Gunther; A. Worsfold; A. Rider

Book ID: 119312403
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.2158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact Of Bone Metastases (Bm) On The Hu

Impact Of Bone Metastases (Bm) On The Humanistic Burden In Patients With Castration-Resistant Prostate Cancer (Crpc)

✍ Hechmati, G.; Arellano, J.; Haynes, I.; Worsfold, A.; Rider, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCN9 Modeling Lifetime Effectiveness of

PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

✍ M. Lothgren; G. Hechmati; I. Jacobs; Y. Qian; J. Arellano 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

714 PAIN AND QUALITY OF LIFE (QOL) ANALY

714 PAIN AND QUALITY OF LIFE (QOL) ANALYSES FROM THE PHASE 3 RANDOMIZED ALSYMPCA STUDY WITH RADIUM-223 DICHLORIDE (RA-223) IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS WITH BONE METASTASES

✍ Tomblyn, Michael; Nilsson, Sten; Vogelzang, Nicholas; Sartor, A. Oliver; Cislo, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

717 EVALUATION OF PROSTATE-SPECIFIC ANTI

717 EVALUATION OF PROSTATE-SPECIFIC ANTIGEN KINETICS DURING ZOLEDRONIC ACID THERAPY FOR BONE METASTASES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

✍ Saad, Fred; Perez, Jose; Cook, Richard; Segal, Scott 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

P124 Long-term safety of radium-223 dich

P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study

✍ Nilsson, S; Schrader, A.J.; Kliment, J.; Solberg, A.; Franzén, L.; Bottomley, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

130 Overall survival benefit and impact

130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)

✍ C. Parker; D. Heinrich; S.I. Helle; J.M O'Sullivan; S Fossä; A. Chodacki; T. Dem 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 107 KB